Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10211522 | Journal of Science and Medicine in Sport | 2018 | 20 Pages |
Abstract
The volleyball career duration and age are dose-response related risk factors for PCHAP among elite indoor and beach volleyball players. DI symptoms are prevalent in a minority of athletes with PCHAP (3/17; 18%). To enable worldwide standardized care for these athletes at risk, four profiles for clinical management and monitoring have been suggested based on questionnaire and ultrasound outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Daan van de Pol, P. Paul F.M. Kuijer, Aart Terpstra, Marja Pannekoek-Hekman, Sena Alaeikhanehshir, Olivier Bouwmeester, R. Nils Planken, Mario Maas,